These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 30890892)

  • 1. Clinical utility of DaTscan™ (123I-Ioflupane Injection) in the diagnosis of Parkinsonian Syndromes.
    Roussakis AA; Piccini P; Politis M
    Degener Neurol Neuromuscul Dis; 2013; 3():33-39. PubMed ID: 30890892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (123I) ioflupane in diagnosis of parkinsonian syndromes.
    Bajaj N; Hauser RA; Grachev ID
    J Neurol Neurosurg Psychiatry; 2013 Nov; 84(11):1288-95. PubMed ID: 23486993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between Hoehn and Yahr, Mini-Mental State Examination, age, and clinical syndrome predominance and diagnostic effectiveness of ioflupane I 123 injection (DaTSCAN™) in subjects with clinically uncertain parkinsonian syndromes.
    Bajaj N; Hauser RA; Seibyl J; Kupsch A; Plotkin M; Chen C; Grachev ID
    Alzheimers Res Ther; 2014; 6(5-8):67. PubMed ID: 25478029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. I
    Quintas S; Sanles-Falagan R; Berbís MÁ
    Mov Disord Clin Pract; 2024 Jun; 11(6):613-625. PubMed ID: 38693679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical utility of DaTscan™ imaging in the evaluation of patients with parkinsonism: a US perspective.
    Isaacson SH; Fisher S; Gupta F; Hermanowicz N; Kremens DE; Lew MF; Marek K; Pahwa R; Russell DS; Seibyl J
    Expert Rev Neurother; 2017 Mar; 17(3):219-225. PubMed ID: 27813429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective and efficient diagnosis of parkinsonism: the role of dopamine transporter SPECT imaging with ioflupane I-123 injection (DaTscan™).
    Cummings JL; Fine MJ; Grachev ID; Jarecke CR; Johnson MK; Kuo PH; Schaecher KL; Oberdorf JA; Rezak M; Riley DE; Truong D
    Am J Manag Care; 2014 Mar; 20(5 Suppl):S97-109. PubMed ID: 24773455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of 123I-ioflupane and 123I-iodobenzamide SPECT scans in 248 patients with parkinsonian syndromes.
    Vlaar AM; de Nijs T; Kessels AG; Vreeling FW; Winogrodzka A; Mess WH; Tromp SC; van Kroonenburgh MJ; Weber WE
    Eur Neurol; 2008; 59(5):258-66. PubMed ID: 18264015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 123I-FP-CIT brain SPECT (DaTSCAN) imaging in the diagnosis of patients with movement disorders--first results.
    Jauković L; Ilić TV; Dopudja M; Ajdinović B
    Vojnosanit Pregl; 2012 Feb; 69(2):157-62. PubMed ID: 22500370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SPECT study with I-123-Ioflupane (DaTSCAN) in patients with essential tremor. Is there any correlation with Parkinson's disease?
    Gerasimou G; Costa DC; Papanastasiou E; Bostanjiopoulou S; Arnaoutoglou M; Moralidis E; Aggelopoulou T; Gotzamani-Psarrakou A
    Ann Nucl Med; 2012 May; 26(4):337-44. PubMed ID: 22382608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effectiveness of 123I-ioflupane (DaTSCAN) in the diagnosis of Parkinsonian syndromes. A systematic review].
    Puñal Riobóo J; Varela Lema L; Serena Puig A; Ruano-Ravina A
    Rev Esp Med Nucl; 2007; 26(6):375-84. PubMed ID: 18021694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [¹²³I]FP-CIT SPECT (DaTSCAN) may be a useful tool to differentiate between Parkinson's disease and vascular or drug-induced parkinsonisms: a meta-analysis.
    Brigo F; Matinella A; Erro R; Tinazzi M
    Eur J Neurol; 2014 Nov; 21(11):1369-e90. PubMed ID: 24779862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [123I]FP-CIT (DaTscan) SPECT brain imaging in patients with suspected parkinsonian syndromes.
    Hauser RA; Grosset DG
    J Neuroimaging; 2012 Jul; 22(3):225-30. PubMed ID: 21410815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration.
    Cummings JL; Henchcliffe C; Schaier S; Simuni T; Waxman A; Kemp P
    Brain; 2011 Nov; 134(Pt 11):3146-66. PubMed ID: 21810889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism.
    Booij J; Speelman JD; Horstink MW; Wolters EC
    Eur J Nucl Med; 2001 Mar; 28(3):266-72. PubMed ID: 11315592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individual-reader diagnostic performance and between-reader agreement in assessment of subjects with Parkinsonian syndrome or dementia using 123I-ioflupane injection (DaTscan) imaging.
    Seibyl JP; Kupsch A; Booij J; Grosset DG; Costa DC; Hauser RA; Darcourt J; Bajaj N; Walker Z; Marek K; McKeith I; O'Brien JT; Tatsch K; Tolosa E; Dierckx RA; Grachev ID
    J Nucl Med; 2014 Aug; 55(8):1288-96. PubMed ID: 24925885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcranial sonography and (123)I-FP-CIT single photon emission computed tomography in movement disorders.
    Bártová P; Kraft O; Bernátek J; Havel M; Ressner P; Langová K; Herzig R; Skoloudík D
    Ultrasound Med Biol; 2014 Oct; 40(10):2365-71. PubMed ID: 25194454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group.
    Benamer TS; Patterson J; Grosset DG; Booij J; de Bruin K; van Royen E; Speelman JD; Horstink MH; Sips HJ; Dierckx RA; Versijpt J; Decoo D; Van Der Linden C; Hadley DM; Doder M; Lees AJ; Costa DC; Gacinovic S; Oertel WH; Pogarell O; Hoeffken H; Joseph K; Tatsch K; Schwarz J; Ries V
    Mov Disord; 2000 May; 15(3):503-10. PubMed ID: 10830416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How useful is (123I) beta-CIT SPECT in the diagnosis of Parkinson's disease?
    Bhidayasiri R
    Rev Neurol Dis; 2006; 3(1):19-22. PubMed ID: 16596082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Impact of 123I-Ioflupane SPECT (DaTscan) in a Movement Disorder Center.
    Graebner AK; Tarsy D; Shih LC; Vanderhorst V; Kulkarni O; Kaplan S; Simon DK
    Neurodegener Dis; 2017; 17(1):38-43. PubMed ID: 27614874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of 123I-Ioflupane SPECT in Patient Management: Essential Tremor.
    Dellavedova L; Giorgetti A; Maffioli LS
    Clin Nucl Med; 2016 Mar; 41(3):e154-5. PubMed ID: 26447386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.